Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Milsaperidone - Vanda Pharmaceuticals

Next Previous
Drug Profile

Milsaperidone - Vanda Pharmaceuticals

Alternative Names: Bysanti; P-88; VHX 869; VHX-896

Latest Information Update: 25 Feb 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Vanda Pharmaceuticals
  • Class 2 ring heterocyclic compounds; Alcohols; Anisoles; Antidepressants; Antipsychotics; Ethers; Fluorobenzenes; Isoxazoles; Methyl ethers; Mood stabilisers; Phenyl ethers; Piperidones; Small molecules
  • Mechanism of Action Alpha 1 adrenergic receptor antagonists; Dopamine D2 receptor antagonists; Serotonin 5-HT2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Bipolar disorders; Schizophrenia
  • Phase III Major depressive disorder

Most Recent Events

  • 25 Feb 2026 Chemical structure information added.
  • 25 Feb 2026 Vanda Pharmaceuticals has patent protection for an improved method of treatment with milsaperidone in USA
  • 25 Feb 2026 Vanda Pharmaceuticals has patents pending for an improved method of treatment with milsaperidone in China, Australia, Israel, Mexico and worldwide

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top